COMMUNIQUÉS West-GlobeNewswire

Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight
14/07/2026
Addressing the Radoff-JEC Group’s Misleading Claims Urges Stockholders to Vote “FOR” Seer’s Director Nominees on the BLUE Proxy Card REDWOOD CITY, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“ [...]
DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026
14/07/2026
Châtillon, France, July 14, 2026 DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026 Company to host investor conference call and webcast at 5:00 p.m. ET DBV [...]
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
14/07/2026
KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the fourth [...]
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
14/07/2026
KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it has entered into a five-year [...]
AVITA Medical to Announce Second Quarter 2026 Financial Results
14/07/2026
VALENCIA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, [...]
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
14/07/2026
FOSTER CITY, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it granted an equity award in the form of a stock option to [...]
Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
14/07/2026
Transaction positions the combined company to execute a capital-efficient, repeatable strategy leveraging public market access and Lōkahi Therapeutics ai²-driven asset sourcing, development, and advancement platform [...]
Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026
14/07/2026
ALAMEDA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, biopharmaceutical company developing novel, miniature, GLP-1 drug implants with once- or [...]
ORIC® Pharmaceuticals Announces Initiation of Himalayas-1 Phase 3 Trial in mCRPC Evaluating Rinzimetostat in Combination with NUBEQA® (Darolutamide), Supported by Clinical Collaboration with Bayer
14/07/2026
Initiated Himalayas-1 global Phase 3 trial in patients with mCRPC previously treated with abiraterone Entered into a clinical trial collaboration and supply agreement with Bayer to provide darolutamide for Himalayas-1 [...]
La Plata County continues to improve code revisions
14/07/2026
Commissioners adopted five Land Use Code amendments that shave weeks off permitting timelines and launched a Proposition 123 “fast-track” for affordable housing — the latest steps in a code-reform effort the county [...]
Acquisition of Own Shares
14/07/2026
Mechelen, Belgium; 14 July 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer
14/07/2026
REVTORPYK is the first and only FDA-approved therapy that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2 In the Phase 3 VIKTORIA-1 trial, REVTORPYK combined with palbociclib and [...]
Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases
14/07/2026
CHICAGO, July 14, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased an [...]
Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
14/07/2026
IM8 is the fastest-growing premium supplement brand ever recorded — over 50 million servings delivered to date, with approximately 200,000 servings currently delivered daily, and an order every 27 seconds Prenetics [...]
Medicana Health Group Opens Belgrade Liaison Office to Strengthen Its Presence in the Balkans
14/07/2026
The new office in Serbia marks an important step in Medicana Health Group’s regional growth strategy and supports its expanding international healthcare network across Europe Photo: Opening ceremony of Medicana Health [...]
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
14/07/2026
Real-World Findings Support Long-Term Benefits of Continuous Treatment with LEQEMBI and Provide Important Insights into Treatment Experience Outside of a Clinical Trial Setting TOKYO and CAMBRIDGE, Mass., July 14, 2026 [...]
Captain James A. Lovell Federal Health Care Center to Treat Post-Traumatic Stress With Virtual Reality Donated by Nonprofit SoldierStrong
14/07/2026
STAMFORD, Conn., July 14, 2026 (GLOBE NEWSWIRE) -- The Captain James A. Lovell Health Care Center in North Chicago, Illinois, is the country’s latest Department of Veterans Affairs facility to partner with national [...]
Gaylord Specialty Healthcare Appoints Dr. Jennifer Russo as Director, Inpatient Acquired Brain Injury Service, Strengthening National Expertise in Stroke and Brain Injury Rehabilitation
14/07/2026
Wallingford, CT, July 14, 2026 (GLOBE NEWSWIRE) -- Gaylord Specialty Healthcare , one of the nation's leading rehabilitation-focused healthcare systems and a recognized destination for stroke rehabilitation and [...]
AscellaHealth Named ACAP Preferred Vendor to Advance Specialty Pharmacy Strategy, Cost Containment and Care Management
14/07/2026
BERWYN, Pa., July 14, 2026 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announces it has been named as a Preferred Vendor [...]

Pages